Literature DB >> 8037658

Interaction of heparin with synthetic antithrombin III peptide analogues.

J Bae1, U R Desai, A Pervin, E E Caldwell, J M Weiler, R J Linhardt.   

Abstract

Heparin-binding proteins may contain specific patterns of basic amino acids, called consensus sequences, that interact with heparin. Small peptides were synthesized that contained consensus sequences (i.e. FAKLNCRLYRKANKSSK) or disrupted consensus sequences (i.e. K136-->A) based on the known sequence of antithrombin III (amino acid residues 123-139). These peptides were then examined in both competitive and non-competitive binding experiments using bioassays, fluorescence spectroscopy, affinity chromatography and n.m.r. spectroscopy. Both the consensus and disrupted-consensus peptide bound to heparin. Peptides with consensus sequences bound specifically to the pentasaccharide antithrombin III-binding site within heparin. In contrast, peptides with disrupted consensus sequences showed no specificity, binding to any sequence within heparin. Proton nuclear Overhauser enhancement spectroscopy demonstrated the proximity of leucine and tyrosine (within the consensus sequence) to the N-acetyl moiety found primarily within the pentasaccharide antithrombin III-binding site of heparin. This experiment confirmed the findings of the other techniques and helped to localize the binding sites in both peptides and heparin. A model is proposed for both specific and non-specific heparin interaction with consensus and disrupted-consensus peptides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037658      PMCID: PMC1137151          DOI: 10.1042/bj3010121

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Probable physiologic functions of heparin.

Authors:  H Engelberg
Journal:  Fed Proc       Date:  1977-01

2.  Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.

Authors:  J Denton; W E Lewis; I A Nieduszynski; C F Phelps
Journal:  Anal Biochem       Date:  1981-12       Impact factor: 3.365

3.  Correlation between structure and function of heparin.

Authors:  R D Rosenberg; L Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 4.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Structure of the antithrombin-binding site in heparin.

Authors:  U Lindahl; G Bäckström; M Höök; L Thunberg; L A Fransson; A Linker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Evaluation of critical groups required for the binding of heparin to antithrombin.

Authors:  D H Atha; A W Stephens; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 7.  Heparin: an old drug with a new paradigm.

Authors:  L B Jacques
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

8.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.

Authors:  J J Castellot; D L Beeler; R D Rosenberg; M J Karnovsky
Journal:  J Cell Physiol       Date:  1984-09       Impact factor: 6.384

9.  Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.

Authors:  R Einarsson; L O Andersson
Journal:  Biochim Biophys Acta       Date:  1977-01-25

10.  Extension and structural variability of the antithrombin-binding sequence in heparin.

Authors:  U Lindahl; L Thunberg; G Bäckström; J Riesenfeld; K Nordling; I Björk
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

View more
  11 in total

1.  Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.

Authors:  Daniel C Pimenta; Iseli L Nantes; Eduardo S de Souza; Bernard Le Bonniec; Amando S Ito; Ivarne L S Tersariol; Vitor Oliveira; Maria A Juliano; Luiz Juliano
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.

Authors:  S Liu; F Zhou; M Höök; D D Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 5.  Glycosaminoglycans in biomedicine.

Authors:  Rebecca A Scott; Alyssa Panitch
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-04-18

Review 6.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

7.  Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity.

Authors:  Kanya Rajangam; Michael S Arnold; Mark A Rocco; Samuel I Stupp
Journal:  Biomaterials       Date:  2008-05-12       Impact factor: 12.479

8.  Facile saccharide-free mimetics that recapitulate key features of glycosaminoglycan sulfation patterns.

Authors:  Teck Chuan Lim; Shuting Cai; Roland G Huber; Peter J Bond; Priscilla Xian Siew Chia; Siv Ly Khou; Shujun Gao; Su Seong Lee; Song-Gil Lee
Journal:  Chem Sci       Date:  2018-08-24       Impact factor: 9.825

9.  The "CPC clip motif": a conserved structural signature for heparin-binding proteins.

Authors:  Marc Torrent; M Victòria Nogués; David Andreu; Ester Boix
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

Review 10.  Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices.

Authors:  Daniel Hachim; Thomas E Whittaker; Hyemin Kim; Molly M Stevens
Journal:  J Control Release       Date:  2019-10-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.